Delivery Order SPE2DB20D3505-SPE2DB24FT3E9
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $19,275.47 and a completion date of December 10, 2024. It is a firm fixed-price contract for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product. The contract is not set aside for any specific business designation. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of OPZELURA 1.5% CREAM 60GM, with a ceiling value of $9,571.46 and a completion date of May 4, 2023. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, with a ceiling value of $9,076.42 and a completion date of June 10, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OPZELURA 1.5% cream. The contract has a ceiling value of $5,111.82 and an ultimate completion date of August 13, 2024. It was awarded on August 12, 2024 as a firm fixed-price contract. The contract is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide 4567504104 OPZELURA 1.5% CREAM 60GM. The fixed-price contract has a ceiling value of $3,908.60 and a period of performance through March 10, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for the company to supply a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of OPZELURA 1.5% CREAM 60GM pharmaceutical products. The $3,737.85 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the U.S. Department of Defense, with an ultimate completion date of March 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,437.27, is for the delivery of OPZELURA 1.5% CREAM 60GM. It has an ultimate completion date of June 6, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OPZELURA 1.5% cream, a pharmaceutical product, with a ceiling value of $3,648.46 and a performance period through May 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,330.79, is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product. The contract has a performance period through May 12, 2023 and is a Firm Fixed Price type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a federal delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product, with a firm fixed price ceiling value of $5,531.02 and a period of performance through July 8, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB24FT3E9Delivery Order
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) for the delivery of OPZELURA 1.5% cream. The contract has a ceiling value of $1,400.93 and an ultimate completion date of November 6, 2023. It is a firm fixed-price contract, indicating the price will not change regardless of the contractor's costs. The contract is not designated as a set-aside, meaning it was competed on an open basis. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/3/23 |